Excess Fat Linked to Weaker Bones in Autoimmune Diabetes
Overview
A pilot study involving 103 adult patients indicates that excess body fat may negatively impact bone strength in patients with autoimmune diabetes, despite normal bone mineral density (BMD) readings. The study highlights the importance of considering body composition over BMD alone in assessing fracture risk.
Background
Understanding the relationship between body fat and bone health is crucial, especially in patients with autoimmune diabetes who are at increased risk for fractures. Traditional assessments like BMD may not fully capture the complexities of bone quality and strength. This study contributes to the growing evidence that body composition, particularly fat distribution, plays a significant role in skeletal health, as evidenced by the use of dual X-ray absorptiometry to assess body composition and bone metrics.
Data Highlights
Key findings include that total fat percentage negatively correlates with bone strength markers at various femur sites, while lean mass percentage shows protective associations.
Key Findings
- Excess fat mass, including visceral adiposity, is associated with impaired hip bone strength and geometry.
- Higher total fat percentage correlates negatively with bone strength markers at various femur sites, including specific measures of cross-sectional moment of inertia.
- Lean mass percentage shows protective associations with trabecular bone scores and structural measures.
- Visceral adipose tissue is an independent risk factor for poorer bone quality.
- Traditional risk factors like older age and female sex are linked to worse bone outcomes in autoimmune diabetes.
Clinical Implications
Clinicians should consider comprehensive assessments of bone quality in patients with autoimmune diabetes, particularly those with overweight or obesity. Relying solely on BMD may underestimate fracture risk, necessitating a more nuanced approach to evaluating skeletal health, potentially using advanced imaging techniques.
Conclusion
The findings underscore the need for a shift in how bone health is assessed in patients with autoimmune diabetes, emphasizing the importance of body composition over traditional measures like BMD, and suggesting further research into comprehensive assessment methods.
Related Resources & Content
- Risi R, et al., Diabetes/Metabolism Research and Reviews, 2023 -- Excess Fat Linked to Weaker Bones in Autoimmune Diabetes
- The Journal of Clinical Endocrinology & Metabolism, 2023 -- Bone Microstructure in Elderly Men with Type 2 Diabetes: Significance of Bone Dimensions
- The Journal of Clinical Endocrinology & Metabolism, 2023 -- F2-Isoprostanes Are Associated With Increased Fracture Risk in Type 2 Diabetes
- The Journal of Clinical Endocrinology & Metabolism, 2023 -- Exploring the Mitochondrial Connection: The Differential Impact of Obesity on Insulin Sensitivity in Black and White Women
- The Journal of Clinical Endocrinology & Metabolism, 2023 -- Identifying Fracture Risk Factors in Middle-Aged and Older Individuals with Type 2 Diabetes and Excess Weight
- American Diabetes Association 2026 Standards of Care
- Bone microarchitecture in type 1 diabetes: the DCCT/EDIC study
- Bone 205 (2026) 117804
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
